Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
4601
4602
4603
4604
4605
4606
4607
4608
4609
4610
4611
4612
4613
4614
4615
4616
4617
4618
4619
4620
4621
4622
4623
4624
4625
4626
4627
4628
4629
4630
4631
4632
4633
4634
4635
4636
4637
4638
4639
4640
4641
4642
4643
4644
4645
4646
4647
4648
4649
4650
4651
4652
4653
4654
4655
4656
4657
4658
4659
4660
4661
4662
4663
4664
4665
4666
4667
4668
4669
4670
4671
4672
4673
4674
4675
4676
4677
4678
4679
4680
4681
4682
4683
4684
4685
4686
4687
4688
4689
4690
4691
4692
4693
4694
4695
4696
4697
4698
4699
4700
4701
4702
4703
4704
4705
4706
4707
4708
4709
4710
4711
4712
4713
4714
4715
4716
4717
4718
4719
4720
4721
4722
4723
4724
4725
4726
4727
4728
4729
4730
4731
4732
4733
4734
4735
4736
4737
4738
4739
4740
4741
4742
4743
4744
4745
4746
4747
4748
4749
4750
4751
4752
4753
4754
4755
4756
4757
4758
4759
4760
4761
4762
4763
4764
4765
4766
4767
4768
4769
4770
4771
4772
4773
4774
4775
4776
4777
4778
4779
4780
4781
4782
4783
4784
4785
4786
4787
4788
4789
4790
4791
4792
4793
4794
4795
4796
4797
4798
4799
4800
| UnnamedSample_HQ_transcript/20873|m.7111 | UnnamedSample_HQ_transcript/20873 | Coverage 0.801 too low. | 1d7ba8c08897afdea5833e87c31ac51c | 960 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 95 | 345 | 6.8E-50 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/15714|m.5620 | UnnamedSample_HQ_transcript/15714 | Coverage 0.812 too low. | 1d7ba8c08897afdea5833e87c31ac51c | 960 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 95 | 345 | 6.8E-50 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/8467|m.3342 | UnnamedSample_HQ_transcript/8467 | Coverage 0.843 too low. | 1d7ba8c08897afdea5833e87c31ac51c | 960 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 95 | 345 | 6.8E-50 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/17552|m.6178 | UnnamedSample_HQ_transcript/17552 | Coverage 0.807 too low. | 1d7ba8c08897afdea5833e87c31ac51c | 960 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 95 | 345 | 6.8E-50 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/15151|m.5446 | UnnamedSample_HQ_transcript/15151 | Coverage 0.812 too low. | 1d7ba8c08897afdea5833e87c31ac51c | 960 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 95 | 345 | 6.8E-50 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/117272|m.24617 | UnnamedSample_HQ_transcript/117272 | Coverage 0.975 too low. | 137821c7d6976965336b3311d1992a4b | 172 | Pfam | PF01576 | Myosin tail | 36 | 168 | 5.1E-16 | T | 22-09-2020 | IPR002928 | Myosin tail |
| UnnamedSample_HQ_transcript/120227|m.24864 | UnnamedSample_HQ_transcript/120227 | Coverage 0.978 too low. | 137821c7d6976965336b3311d1992a4b | 172 | Pfam | PF01576 | Myosin tail | 36 | 168 | 5.1E-16 | T | 22-09-2020 | IPR002928 | Myosin tail |
| UnnamedSample_HQ_transcript/81780|m.19996 | UnnamedSample_HQ_transcript/81780 | Coverage 0.916 too low. | a59852071cae208a9b2a80ce6040e1fc | 321 | Pfam | PF00089 | Trypsin | 68 | 313 | 5.4E-54 | T | 22-09-2020 | IPR001254 | Serine proteases, trypsin domain |
| UnnamedSample_HQ_transcript/68702|m.17708 | UnnamedSample_HQ_transcript/68702 | Identity 0.718 too low. | a59852071cae208a9b2a80ce6040e1fc | 321 | Pfam | PF00089 | Trypsin | 68 | 313 | 5.4E-54 | T | 22-09-2020 | IPR001254 | Serine proteases, trypsin domain |
| UnnamedSample_HQ_transcript/84137|m.20366 | UnnamedSample_HQ_transcript/84137 | Coverage 0.764 too low. | a59852071cae208a9b2a80ce6040e1fc | 321 | Pfam | PF00089 | Trypsin | 68 | 313 | 5.4E-54 | T | 22-09-2020 | IPR001254 | Serine proteases, trypsin domain |
| UnnamedSample_HQ_transcript/85644|m.20591 | UnnamedSample_HQ_transcript/85644 | Coverage 0.775 too low. | a59852071cae208a9b2a80ce6040e1fc | 321 | Pfam | PF00089 | Trypsin | 68 | 313 | 5.4E-54 | T | 22-09-2020 | IPR001254 | Serine proteases, trypsin domain |
| UnnamedSample_HQ_transcript/63654|m.16769 | UnnamedSample_HQ_transcript/63654 | Coverage 0.986 too low. | c608649deeecccc32bc75e35e75a0d5e | 633 | Pfam | PF08063 | PADR1 (NUC008) domain | 119 | 171 | 1.1E-18 | T | 22-09-2020 | IPR012982 | PADR1 domain |
| UnnamedSample_HQ_transcript/63654|m.16769 | UnnamedSample_HQ_transcript/63654 | Coverage 0.986 too low. | c608649deeecccc32bc75e35e75a0d5e | 633 | Pfam | PF00644 | Poly(ADP-ribose) polymerase catalytic domain | 506 | 632 | 1.9E-45 | T | 22-09-2020 | IPR012317 | Poly(ADP-ribose) polymerase, catalytic domain |
| UnnamedSample_HQ_transcript/63654|m.16769 | UnnamedSample_HQ_transcript/63654 | Coverage 0.986 too low. | c608649deeecccc32bc75e35e75a0d5e | 633 | Pfam | PF05406 | WGR domain | 253 | 332 | 2.3E-19 | T | 22-09-2020 | IPR008893 | WGR domain |
| UnnamedSample_HQ_transcript/63654|m.16769 | UnnamedSample_HQ_transcript/63654 | Coverage 0.986 too low. | c608649deeecccc32bc75e35e75a0d5e | 633 | Pfam | PF02877 | Poly(ADP-ribose) polymerase, regulatory domain | 355 | 491 | 2.2E-42 | T | 22-09-2020 | IPR004102 | Poly(ADP-ribose) polymerase, regulatory domain |
| UnnamedSample_HQ_transcript/118221|m.24697 | UnnamedSample_HQ_transcript/118221 | Identity 0.941 too low. | bf5ffacaddba9385505fb9bcbc03196d | 151 | Pfam | PF15868 | Transcription activator MBF2 | 57 | 148 | 6.4E-8 | T | 22-09-2020 | IPR031734 | Transcription activator MBF2 |
| UnnamedSample_HQ_transcript/121778|m.24977 | UnnamedSample_HQ_transcript/121778 | Identity 0.940 too low. | bf5ffacaddba9385505fb9bcbc03196d | 151 | Pfam | PF15868 | Transcription activator MBF2 | 57 | 148 | 6.4E-8 | T | 22-09-2020 | IPR031734 | Transcription activator MBF2 |
| UnnamedSample_HQ_transcript/108247|m.23611 | UnnamedSample_HQ_transcript/108247 | Coverage 0.857 too low. | faba42d0a4776d9d81fc45165f99de5d | 265 | Pfam | PF04821 | Timeless protein | 24 | 262 | 1.1E-60 | T | 22-09-2020 | IPR006906 | Timeless, N-terminal |
| UnnamedSample_HQ_transcript/28714|m.9144 | UnnamedSample_HQ_transcript/28714 | Coverage 0.825 too low. | efb1e400e57d9859674c76b1e9546628 | 687 | Pfam | PF00063 | Myosin head (motor domain) | 90 | 501 | 9.8E-181 | T | 22-09-2020 | IPR001609 | Myosin head, motor domain |
| UnnamedSample_HQ_transcript/28714|m.9144 | UnnamedSample_HQ_transcript/28714 | Coverage 0.825 too low. | efb1e400e57d9859674c76b1e9546628 | 687 | Pfam | PF02736 | Myosin N-terminal SH3-like domain | 36 | 75 | 1.5E-12 | T | 22-09-2020 | IPR004009 | Myosin, N-terminal, SH3-like |
| UnnamedSample_HQ_transcript/105382|m.23272 | UnnamedSample_HQ_transcript/105382 | Identity 0.940 too low. | 1e38e6f68b250153ce5e340ffef7014a | 283 | Pfam | PF07679 | Immunoglobulin I-set domain | 154 | 243 | 2.7E-8 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/12400|m.4620 | UnnamedSample_HQ_transcript/12400 | Coverage 0.195 too low. | e75541ae4fca40804b5235e6f714be6f | 1014 | Pfam | PF00105 | Zinc finger, C4 type (two domains) | 62 | 131 | 6.2E-31 | T | 22-09-2020 | IPR001628 | Zinc finger, nuclear hormone receptor-type |
| UnnamedSample_HQ_transcript/12400|m.4620 | UnnamedSample_HQ_transcript/12400 | Coverage 0.195 too low. | e75541ae4fca40804b5235e6f714be6f | 1014 | Pfam | PF00104 | Ligand-binding domain of nuclear hormone receptor | 232 | 406 | 4.1E-19 | T | 22-09-2020 | IPR000536 | Nuclear hormone receptor, ligand-binding domain |
| UnnamedSample_HQ_transcript/3125|m.1493 | UnnamedSample_HQ_transcript/3125 | Coverage 0.157 too low. | e75541ae4fca40804b5235e6f714be6f | 1014 | Pfam | PF00105 | Zinc finger, C4 type (two domains) | 62 | 131 | 6.2E-31 | T | 22-09-2020 | IPR001628 | Zinc finger, nuclear hormone receptor-type |
| UnnamedSample_HQ_transcript/3125|m.1493 | UnnamedSample_HQ_transcript/3125 | Coverage 0.157 too low. | e75541ae4fca40804b5235e6f714be6f | 1014 | Pfam | PF00104 | Ligand-binding domain of nuclear hormone receptor | 232 | 406 | 4.1E-19 | T | 22-09-2020 | IPR000536 | Nuclear hormone receptor, ligand-binding domain |
| UnnamedSample_HQ_transcript/4191|m.1880 | UnnamedSample_HQ_transcript/4191 | Coverage 0.152 too low. | e75541ae4fca40804b5235e6f714be6f | 1014 | Pfam | PF00105 | Zinc finger, C4 type (two domains) | 62 | 131 | 6.2E-31 | T | 22-09-2020 | IPR001628 | Zinc finger, nuclear hormone receptor-type |
| UnnamedSample_HQ_transcript/4191|m.1880 | UnnamedSample_HQ_transcript/4191 | Coverage 0.152 too low. | e75541ae4fca40804b5235e6f714be6f | 1014 | Pfam | PF00104 | Ligand-binding domain of nuclear hormone receptor | 232 | 406 | 4.1E-19 | T | 22-09-2020 | IPR000536 | Nuclear hormone receptor, ligand-binding domain |
| UnnamedSample_HQ_transcript/10978|m.4141 | UnnamedSample_HQ_transcript/10978 | Coverage 0.212 too low. | e75541ae4fca40804b5235e6f714be6f | 1014 | Pfam | PF00105 | Zinc finger, C4 type (two domains) | 62 | 131 | 6.2E-31 | T | 22-09-2020 | IPR001628 | Zinc finger, nuclear hormone receptor-type |
| UnnamedSample_HQ_transcript/10978|m.4141 | UnnamedSample_HQ_transcript/10978 | Coverage 0.212 too low. | e75541ae4fca40804b5235e6f714be6f | 1014 | Pfam | PF00104 | Ligand-binding domain of nuclear hormone receptor | 232 | 406 | 4.1E-19 | T | 22-09-2020 | IPR000536 | Nuclear hormone receptor, ligand-binding domain |
| UnnamedSample_HQ_transcript/3754|m.1715 | UnnamedSample_HQ_transcript/3754 | Coverage 0.171 too low. | e75541ae4fca40804b5235e6f714be6f | 1014 | Pfam | PF00105 | Zinc finger, C4 type (two domains) | 62 | 131 | 6.2E-31 | T | 22-09-2020 | IPR001628 | Zinc finger, nuclear hormone receptor-type |
| UnnamedSample_HQ_transcript/3754|m.1715 | UnnamedSample_HQ_transcript/3754 | Coverage 0.171 too low. | e75541ae4fca40804b5235e6f714be6f | 1014 | Pfam | PF00104 | Ligand-binding domain of nuclear hormone receptor | 232 | 406 | 4.1E-19 | T | 22-09-2020 | IPR000536 | Nuclear hormone receptor, ligand-binding domain |
| UnnamedSample_HQ_transcript/10254|m.3905 | UnnamedSample_HQ_transcript/10254 | Coverage 0.209 too low. | e75541ae4fca40804b5235e6f714be6f | 1014 | Pfam | PF00105 | Zinc finger, C4 type (two domains) | 62 | 131 | 6.2E-31 | T | 22-09-2020 | IPR001628 | Zinc finger, nuclear hormone receptor-type |
| UnnamedSample_HQ_transcript/10254|m.3905 | UnnamedSample_HQ_transcript/10254 | Coverage 0.209 too low. | e75541ae4fca40804b5235e6f714be6f | 1014 | Pfam | PF00104 | Ligand-binding domain of nuclear hormone receptor | 232 | 406 | 4.1E-19 | T | 22-09-2020 | IPR000536 | Nuclear hormone receptor, ligand-binding domain |
| UnnamedSample_HQ_transcript/14842|m.5365 | UnnamedSample_HQ_transcript/14842 | Identity 0.740 too low. | cf45d34088d85901655c95f6864c3ab0 | 185 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 94 | 157 | 5.5E-16 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/10470|m.3977 | UnnamedSample_HQ_transcript/10470 | Coverage 0.930 too low. | fb549e7bbf5adf57e99ff23a5ab0fa5c | 1061 | Pfam | PF01751 | Toprim domain | 457 | 558 | 5.6E-8 | T | 22-09-2020 | IPR006171 | TOPRIM domain |
| UnnamedSample_HQ_transcript/10470|m.3977 | UnnamedSample_HQ_transcript/10470 | Coverage 0.930 too low. | fb549e7bbf5adf57e99ff23a5ab0fa5c | 1061 | Pfam | PF00521 | DNA gyrase/topoisomerase IV, subunit A | 718 | 1013 | 2.3E-97 | T | 22-09-2020 | IPR002205 | DNA topoisomerase, type IIA, subunit A/C-terminal |
| UnnamedSample_HQ_transcript/10470|m.3977 | UnnamedSample_HQ_transcript/10470 | Coverage 0.930 too low. | fb549e7bbf5adf57e99ff23a5ab0fa5c | 1061 | Pfam | PF02518 | Histidine kinase-, DNA gyrase B-, and HSP90-like ATPase | 81 | 225 | 1.1E-15 | T | 22-09-2020 | IPR003594 | Histidine kinase/HSP90-like ATPase |
| UnnamedSample_HQ_transcript/10470|m.3977 | UnnamedSample_HQ_transcript/10470 | Coverage 0.930 too low. | fb549e7bbf5adf57e99ff23a5ab0fa5c | 1061 | Pfam | PF00204 | DNA gyrase B | 268 | 428 | 5.0E-26 | T | 22-09-2020 | IPR013506 | DNA topoisomerase, type IIA, subunit B, domain 2 |
| UnnamedSample_HQ_transcript/10470|m.3977 | UnnamedSample_HQ_transcript/10470 | Coverage 0.930 too low. | fb549e7bbf5adf57e99ff23a5ab0fa5c | 1061 | Pfam | PF16898 | C-terminal associated domain of TOPRIM | 573 | 716 | 7.1E-48 | T | 22-09-2020 | IPR031660 | C-terminal associated domain of TOPRIM |
| UnnamedSample_HQ_transcript/62961|m.16617 | UnnamedSample_HQ_transcript/62961 | Coverage 0.751 too low. | 4356d0d08ee2d1a73cf137d205b821c6 | 446 | Pfam | PF00105 | Zinc finger, C4 type (two domains) | 89 | 157 | 2.4E-29 | T | 22-09-2020 | IPR001628 | Zinc finger, nuclear hormone receptor-type |
| UnnamedSample_HQ_transcript/62961|m.16617 | UnnamedSample_HQ_transcript/62961 | Coverage 0.751 too low. | 4356d0d08ee2d1a73cf137d205b821c6 | 446 | Pfam | PF00104 | Ligand-binding domain of nuclear hormone receptor | 208 | 398 | 1.3E-42 | T | 22-09-2020 | IPR000536 | Nuclear hormone receptor, ligand-binding domain |
| UnnamedSample_HQ_transcript/3848|m.1754 | UnnamedSample_HQ_transcript/3848 | Coverage 0.718 too low. | cac370199c2c2d9e7be56444bad8ee0c | 740 | Pfam | PF00435 | Spectrin repeat | 180 | 275 | 3.1E-5 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/3848|m.1754 | UnnamedSample_HQ_transcript/3848 | Coverage 0.718 too low. | cac370199c2c2d9e7be56444bad8ee0c | 740 | Pfam | PF00435 | Spectrin repeat | 79 | 168 | 4.5E-6 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/77480|m.19284 | UnnamedSample_HQ_transcript/77480 | Coverage 0.598 too low. | de4d64ff6cff177acefd588ccc370ca9 | 276 | Pfam | PF00122 | E1-E2 ATPase | 169 | 270 | 2.5E-24 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/77480|m.19284 | UnnamedSample_HQ_transcript/77480 | Coverage 0.598 too low. | de4d64ff6cff177acefd588ccc370ca9 | 276 | Pfam | PF00690 | Cation transporter/ATPase, N-terminus | 37 | 104 | 1.0E-17 | T | 22-09-2020 | IPR004014 | Cation-transporting P-type ATPase, N-terminal |
| UnnamedSample_HQ_transcript/7380|m.2979 | UnnamedSample_HQ_transcript/7380 | Coverage 0.038 too low. | f2a228bccf4d23879763d26e3f841e73 | 1348 | Pfam | PF00041 | Fibronectin type III domain | 951 | 1024 | 5.8E-11 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/7380|m.2979 | UnnamedSample_HQ_transcript/7380 | Coverage 0.038 too low. | f2a228bccf4d23879763d26e3f841e73 | 1348 | Pfam | PF07679 | Immunoglobulin I-set domain | 735 | 819 | 2.7E-13 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/7380|m.2979 | UnnamedSample_HQ_transcript/7380 | Coverage 0.038 too low. | f2a228bccf4d23879763d26e3f841e73 | 1348 | Pfam | PF07679 | Immunoglobulin I-set domain | 244 | 336 | 1.6E-16 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/7380|m.2979 | UnnamedSample_HQ_transcript/7380 | Coverage 0.038 too low. | f2a228bccf4d23879763d26e3f841e73 | 1348 | Pfam | PF07679 | Immunoglobulin I-set domain | 30 | 120 | 1.9E-17 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/7380|m.2979 | UnnamedSample_HQ_transcript/7380 | Coverage 0.038 too low. | f2a228bccf4d23879763d26e3f841e73 | 1348 | Pfam | PF07679 | Immunoglobulin I-set domain | 517 | 606 | 2.2E-19 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/7380|m.2979 | UnnamedSample_HQ_transcript/7380 | Coverage 0.038 too low. | f2a228bccf4d23879763d26e3f841e73 | 1348 | Pfam | PF07679 | Immunoglobulin I-set domain | 850 | 935 | 2.3E-16 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/7380|m.2979 | UnnamedSample_HQ_transcript/7380 | Coverage 0.038 too low. | f2a228bccf4d23879763d26e3f841e73 | 1348 | Pfam | PF07679 | Immunoglobulin I-set domain | 365 | 457 | 9.8E-15 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/7380|m.2979 | UnnamedSample_HQ_transcript/7380 | Coverage 0.038 too low. | f2a228bccf4d23879763d26e3f841e73 | 1348 | Pfam | PF07679 | Immunoglobulin I-set domain | 626 | 714 | 5.6E-12 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/7380|m.2979 | UnnamedSample_HQ_transcript/7380 | Coverage 0.038 too low. | f2a228bccf4d23879763d26e3f841e73 | 1348 | Pfam | PF07679 | Immunoglobulin I-set domain | 131 | 221 | 1.1E-15 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/7380|m.2979 | UnnamedSample_HQ_transcript/7380 | Coverage 0.038 too low. | f2a228bccf4d23879763d26e3f841e73 | 1348 | Pfam | PF00069 | Protein kinase domain | 1058 | 1313 | 1.1E-70 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/60499|m.16160 | UnnamedSample_HQ_transcript/60499 | Coverage 0.504 too low. | fff953d743f249302cc8862be3a99e12 | 278 | Pfam | PF05485 | THAP domain | 70 | 140 | 1.8E-10 | T | 22-09-2020 | IPR006612 | THAP-type zinc finger |
| UnnamedSample_HQ_transcript/26438|m.8589 | UnnamedSample_HQ_transcript/26438 | Coverage 0.930 too low. | 3aa6c11f2af06bc5997a614d4c5cc26b | 672 | Pfam | PF07177 | Neuralized | 295 | 445 | 2.4E-30 | T | 22-09-2020 | IPR006573 | Neuralized homology repeat (NHR) domain |
| UnnamedSample_HQ_transcript/26438|m.8589 | UnnamedSample_HQ_transcript/26438 | Coverage 0.930 too low. | 3aa6c11f2af06bc5997a614d4c5cc26b | 672 | Pfam | PF07177 | Neuralized | 48 | 196 | 1.1E-48 | T | 22-09-2020 | IPR006573 | Neuralized homology repeat (NHR) domain |
| UnnamedSample_HQ_transcript/26438|m.8589 | UnnamedSample_HQ_transcript/26438 | Coverage 0.930 too low. | 3aa6c11f2af06bc5997a614d4c5cc26b | 672 | Pfam | PF13920 | Zinc finger, C3HC4 type (RING finger) | 617 | 666 | 1.4E-13 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/19006|m.6583 | UnnamedSample_HQ_transcript/19006 | Coverage 0.481 too low. | 971b74e390a785f88da98a2ecef1902d | 428 | Pfam | PF14800 | Domain of unknown function (DUF4481) | 128 | 301 | 8.8E-13 | T | 22-09-2020 | IPR028054 | Protein of unknown function DUF4481 |
| UnnamedSample_HQ_transcript/18733|m.6511 | UnnamedSample_HQ_transcript/18733 | Coverage 0.473 too low. | 971b74e390a785f88da98a2ecef1902d | 428 | Pfam | PF14800 | Domain of unknown function (DUF4481) | 128 | 301 | 8.8E-13 | T | 22-09-2020 | IPR028054 | Protein of unknown function DUF4481 |
| UnnamedSample_HQ_transcript/19122|m.6616 | UnnamedSample_HQ_transcript/19122 | Unmapped. | 078bbe9e0be90ffacc7485c4f89e894c | 506 | Pfam | PF08762 | CRPV capsid protein like | 61 | 271 | 4.6E-12 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/84107|m.20357 | UnnamedSample_HQ_transcript/84107 | Coverage 0.405 too low. | a7fe4e1063a94e656eb81fd07456b4ad | 182 | Pfam | PF00102 | Protein-tyrosine phosphatase | 32 | 175 | 7.6E-30 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/99872|m.22614 | UnnamedSample_HQ_transcript/99872 | Coverage 0.767 too low. | b142e58d1c301698a7fa3a86cbb53b40 | 297 | Pfam | PF05199 | GMC oxidoreductase | 139 | 283 | 4.1E-39 | T | 22-09-2020 | IPR007867 | Glucose-methanol-choline oxidoreductase, C-terminal |
| UnnamedSample_HQ_transcript/99872|m.22614 | UnnamedSample_HQ_transcript/99872 | Coverage 0.767 too low. | b142e58d1c301698a7fa3a86cbb53b40 | 297 | Pfam | PF00732 | GMC oxidoreductase | 1 | 32 | 2.8E-6 | T | 22-09-2020 | IPR000172 | Glucose-methanol-choline oxidoreductase, N-terminal |
| UnnamedSample_HQ_transcript/40676|m.12003 | UnnamedSample_HQ_transcript/40676 | Coverage 0.884 too low. | 29b8bcbd5c95117c09bc0d276c3ceda6 | 542 | Pfam | PF00135 | Carboxylesterase family | 21 | 532 | 1.7E-138 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/21975|m.7424 | UnnamedSample_HQ_transcript/21975 | Coverage 0.887 too low. | 7cdf52eedd8838f8186333a57ec9a6f3 | 766 | Pfam | PF13360 | PQQ-like domain | 699 | 763 | 4.6E-5 | T | 22-09-2020 | IPR002372 | Pyrrolo-quinoline quinone repeat |
| UnnamedSample_HQ_transcript/21975|m.7424 | UnnamedSample_HQ_transcript/21975 | Coverage 0.887 too low. | 7cdf52eedd8838f8186333a57ec9a6f3 | 766 | Pfam | PF13193 | AMP-binding enzyme C-terminal domain | 405 | 475 | 1.7E-5 | T | 22-09-2020 | IPR025110 | AMP-binding enzyme, C-terminal domain |
| UnnamedSample_HQ_transcript/21975|m.7424 | UnnamedSample_HQ_transcript/21975 | Coverage 0.887 too low. | 7cdf52eedd8838f8186333a57ec9a6f3 | 766 | Pfam | PF00501 | AMP-binding enzyme | 10 | 396 | 2.0E-35 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/36922|m.11149 | UnnamedSample_HQ_transcript/36922 | Coverage 0.156 too low. | 831b4922d20df7ee88a0ab82393dd4f9 | 524 | Pfam | PF01145 | SPFH domain / Band 7 family | 57 | 109 | 5.5E-5 | T | 22-09-2020 | IPR001107 | Band 7 domain |
| UnnamedSample_HQ_transcript/36922|m.11149 | UnnamedSample_HQ_transcript/36922 | Coverage 0.156 too low. | 831b4922d20df7ee88a0ab82393dd4f9 | 524 | Pfam | PF00505 | HMG (high mobility group) box | 117 | 185 | 7.2E-25 | T | 22-09-2020 | IPR009071 | High mobility group box domain |
| UnnamedSample_HQ_transcript/105425|m.23278 | UnnamedSample_HQ_transcript/105425 | Coverage 0.989 too low. | 15c5143ec9d2a30b5cf38cffb3c8ce49 | 209 | Pfam | PF03371 | PRP38 family | 28 | 207 | 6.0E-54 | T | 22-09-2020 | IPR005037 | Pre-mRNA-splicing factor 38 |
| UnnamedSample_HQ_transcript/37936|m.11383 | UnnamedSample_HQ_transcript/37936 | Coverage 0.979 too low. | 212560bfacaad09f52347fd5d2c76c8a | 580 | Pfam | PF00069 | Protein kinase domain | 20 | 295 | 4.2E-63 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/43837|m.12673 | UnnamedSample_HQ_transcript/43837 | Coverage 0.954 too low. | b313afa846b18ec7760e3b53705da3bb | 578 | Pfam | PF00397 | WW domain | 251 | 280 | 3.0E-9 | T | 22-09-2020 | IPR001202 | WW domain |
| UnnamedSample_HQ_transcript/43837|m.12673 | UnnamedSample_HQ_transcript/43837 | Coverage 0.954 too low. | b313afa846b18ec7760e3b53705da3bb | 578 | Pfam | PF00397 | WW domain | 27 | 56 | 2.7E-12 | T | 22-09-2020 | IPR001202 | WW domain |
| UnnamedSample_HQ_transcript/43837|m.12673 | UnnamedSample_HQ_transcript/43837 | Coverage 0.954 too low. | b313afa846b18ec7760e3b53705da3bb | 578 | Pfam | PF00632 | HECT-domain (ubiquitin-transferase) | 447 | 578 | 1.4E-30 | T | 22-09-2020 | IPR000569 | HECT domain |
| UnnamedSample_HQ_transcript/12331|m.4599 | UnnamedSample_HQ_transcript/12331 | Coverage 0.142 too low. | c5eaf95fbf8ff4e28702c35f70998f0b | 504 | Pfam | PF07671 | Protein of unknown function (DUF1601) | 252 | 266 | 13 | T | 22-09-2020 | IPR011632 | Domain of unknown function DUF1601 |
| UnnamedSample_HQ_transcript/12331|m.4599 | UnnamedSample_HQ_transcript/12331 | Coverage 0.142 too low. | c5eaf95fbf8ff4e28702c35f70998f0b | 504 | Pfam | PF07671 | Protein of unknown function (DUF1601) | 429 | 442 | 0.84 | T | 22-09-2020 | IPR011632 | Domain of unknown function DUF1601 |
| UnnamedSample_HQ_transcript/12331|m.4599 | UnnamedSample_HQ_transcript/12331 | Coverage 0.142 too low. | c5eaf95fbf8ff4e28702c35f70998f0b | 504 | Pfam | PF07671 | Protein of unknown function (DUF1601) | 348 | 358 | 33 | T | 22-09-2020 | IPR011632 | Domain of unknown function DUF1601 |
| UnnamedSample_HQ_transcript/12331|m.4599 | UnnamedSample_HQ_transcript/12331 | Coverage 0.142 too low. | c5eaf95fbf8ff4e28702c35f70998f0b | 504 | Pfam | PF07671 | Protein of unknown function (DUF1601) | 470 | 483 | 3.1 | T | 22-09-2020 | IPR011632 | Domain of unknown function DUF1601 |
| UnnamedSample_HQ_transcript/12331|m.4599 | UnnamedSample_HQ_transcript/12331 | Coverage 0.142 too low. | c5eaf95fbf8ff4e28702c35f70998f0b | 504 | Pfam | PF07671 | Protein of unknown function (DUF1601) | 180 | 201 | 0.66 | T | 22-09-2020 | IPR011632 | Domain of unknown function DUF1601 |
| UnnamedSample_HQ_transcript/58791|m.15814 | UnnamedSample_HQ_transcript/58791 | Coverage 0.140 too low. | 88e0185327788e08a0798fa571349b13 | 518 | Pfam | PF03454 | MoeA C-terminal region (domain IV) | 441 | 502 | 1.1E-7 | T | 22-09-2020 | IPR005111 | MoeA, C-terminal, domain IV |
| UnnamedSample_HQ_transcript/58791|m.15814 | UnnamedSample_HQ_transcript/58791 | Coverage 0.140 too low. | 88e0185327788e08a0798fa571349b13 | 518 | Pfam | PF00994 | Probable molybdopterin binding domain | 284 | 426 | 1.5E-23 | T | 22-09-2020 | IPR001453 | MoaB/Mog domain |
| UnnamedSample_HQ_transcript/58791|m.15814 | UnnamedSample_HQ_transcript/58791 | Coverage 0.140 too low. | 88e0185327788e08a0798fa571349b13 | 518 | Pfam | PF03453 | MoeA N-terminal region (domain I and II) | 108 | 271 | 3.3E-41 | T | 22-09-2020 | IPR005110 | MoeA, N-terminal and linker domain |
| UnnamedSample_HQ_transcript/84826|m.20467 | UnnamedSample_HQ_transcript/84826 | Coverage 0.706 too low. | 8f6a1e5c72490ff41741134fb1c76d09 | 404 | Pfam | PF00107 | Zinc-binding dehydrogenase | 188 | 317 | 1.2E-13 | T | 22-09-2020 | IPR013149 | Alcohol dehydrogenase, C-terminal |
| UnnamedSample_HQ_transcript/84826|m.20467 | UnnamedSample_HQ_transcript/84826 | Coverage 0.706 too low. | 8f6a1e5c72490ff41741134fb1c76d09 | 404 | Pfam | PF08240 | Alcohol dehydrogenase GroES-like domain | 65 | 124 | 2.7E-13 | T | 22-09-2020 | IPR013154 | Alcohol dehydrogenase, N-terminal |
| UnnamedSample_HQ_transcript/18362|m.6409 | UnnamedSample_HQ_transcript/18362 | Coverage 0.966 too low. | 9b71f876b30e9ac003a04e8f70db45a6 | 939 | Pfam | PF02882 | Tetrahydrofolate dehydrogenase/cyclohydrolase, NAD(P)-binding domain | 133 | 298 | 1.3E-62 | T | 22-09-2020 | IPR020631 | Tetrahydrofolate dehydrogenase/cyclohydrolase, NAD(P)-binding domain |
| UnnamedSample_HQ_transcript/18362|m.6409 | UnnamedSample_HQ_transcript/18362 | Coverage 0.966 too low. | 9b71f876b30e9ac003a04e8f70db45a6 | 939 | Pfam | PF01268 | Formate--tetrahydrofolate ligase | 322 | 939 | 3.8E-248 | T | 22-09-2020 | IPR000559 | Formate-tetrahydrofolate ligase, FTHFS |
| UnnamedSample_HQ_transcript/18362|m.6409 | UnnamedSample_HQ_transcript/18362 | Coverage 0.966 too low. | 9b71f876b30e9ac003a04e8f70db45a6 | 939 | Pfam | PF00763 | Tetrahydrofolate dehydrogenase/cyclohydrolase, catalytic domain | 11 | 130 | 1.4E-36 | T | 22-09-2020 | IPR020630 | Tetrahydrofolate dehydrogenase/cyclohydrolase, catalytic domain |
| UnnamedSample_HQ_transcript/16533|m.5866 | UnnamedSample_HQ_transcript/16533 | Coverage 0.932 too low. | 9b71f876b30e9ac003a04e8f70db45a6 | 939 | Pfam | PF02882 | Tetrahydrofolate dehydrogenase/cyclohydrolase, NAD(P)-binding domain | 133 | 298 | 1.3E-62 | T | 22-09-2020 | IPR020631 | Tetrahydrofolate dehydrogenase/cyclohydrolase, NAD(P)-binding domain |
| UnnamedSample_HQ_transcript/16533|m.5866 | UnnamedSample_HQ_transcript/16533 | Coverage 0.932 too low. | 9b71f876b30e9ac003a04e8f70db45a6 | 939 | Pfam | PF01268 | Formate--tetrahydrofolate ligase | 322 | 939 | 3.8E-248 | T | 22-09-2020 | IPR000559 | Formate-tetrahydrofolate ligase, FTHFS |
| UnnamedSample_HQ_transcript/16533|m.5866 | UnnamedSample_HQ_transcript/16533 | Coverage 0.932 too low. | 9b71f876b30e9ac003a04e8f70db45a6 | 939 | Pfam | PF00763 | Tetrahydrofolate dehydrogenase/cyclohydrolase, catalytic domain | 11 | 130 | 1.4E-36 | T | 22-09-2020 | IPR020630 | Tetrahydrofolate dehydrogenase/cyclohydrolase, catalytic domain |
| UnnamedSample_HQ_transcript/19544|m.6739 | UnnamedSample_HQ_transcript/19544 | Coverage 0.985 too low. | 9b71f876b30e9ac003a04e8f70db45a6 | 939 | Pfam | PF02882 | Tetrahydrofolate dehydrogenase/cyclohydrolase, NAD(P)-binding domain | 133 | 298 | 1.3E-62 | T | 22-09-2020 | IPR020631 | Tetrahydrofolate dehydrogenase/cyclohydrolase, NAD(P)-binding domain |
| UnnamedSample_HQ_transcript/19544|m.6739 | UnnamedSample_HQ_transcript/19544 | Coverage 0.985 too low. | 9b71f876b30e9ac003a04e8f70db45a6 | 939 | Pfam | PF01268 | Formate--tetrahydrofolate ligase | 322 | 939 | 3.8E-248 | T | 22-09-2020 | IPR000559 | Formate-tetrahydrofolate ligase, FTHFS |
| UnnamedSample_HQ_transcript/19544|m.6739 | UnnamedSample_HQ_transcript/19544 | Coverage 0.985 too low. | 9b71f876b30e9ac003a04e8f70db45a6 | 939 | Pfam | PF00763 | Tetrahydrofolate dehydrogenase/cyclohydrolase, catalytic domain | 11 | 130 | 1.4E-36 | T | 22-09-2020 | IPR020630 | Tetrahydrofolate dehydrogenase/cyclohydrolase, catalytic domain |
| UnnamedSample_HQ_transcript/18339|m.6404 | UnnamedSample_HQ_transcript/18339 | Coverage 0.965 too low. | 9b71f876b30e9ac003a04e8f70db45a6 | 939 | Pfam | PF02882 | Tetrahydrofolate dehydrogenase/cyclohydrolase, NAD(P)-binding domain | 133 | 298 | 1.3E-62 | T | 22-09-2020 | IPR020631 | Tetrahydrofolate dehydrogenase/cyclohydrolase, NAD(P)-binding domain |
| UnnamedSample_HQ_transcript/18339|m.6404 | UnnamedSample_HQ_transcript/18339 | Coverage 0.965 too low. | 9b71f876b30e9ac003a04e8f70db45a6 | 939 | Pfam | PF01268 | Formate--tetrahydrofolate ligase | 322 | 939 | 3.8E-248 | T | 22-09-2020 | IPR000559 | Formate-tetrahydrofolate ligase, FTHFS |
| UnnamedSample_HQ_transcript/18339|m.6404 | UnnamedSample_HQ_transcript/18339 | Coverage 0.965 too low. | 9b71f876b30e9ac003a04e8f70db45a6 | 939 | Pfam | PF00763 | Tetrahydrofolate dehydrogenase/cyclohydrolase, catalytic domain | 11 | 130 | 1.4E-36 | T | 22-09-2020 | IPR020630 | Tetrahydrofolate dehydrogenase/cyclohydrolase, catalytic domain |
| UnnamedSample_HQ_transcript/80873|m.19854 | UnnamedSample_HQ_transcript/80873 | Coverage 0.540 too low. | ea47df25e10f044722a3def954c3c998 | 353 | Pfam | PF06367 | Diaphanous FH3 Domain | 49 | 231 | 2.7E-29 | T | 22-09-2020 | IPR010472 | Formin, FH3 domain |
| UnnamedSample_HQ_transcript/109073|m.23724 | UnnamedSample_HQ_transcript/109073 | Coverage 0.970 too low. | 7a1db2e7e12bcbc8105daf3759820248 | 277 | Pfam | PF00063 | Myosin head (motor domain) | 1 | 106 | 5.5E-39 | T | 22-09-2020 | IPR001609 | Myosin head, motor domain |
| UnnamedSample_HQ_transcript/89321|m.21132 | UnnamedSample_HQ_transcript/89321 | Coverage 0.937 too low. | c317650619ec1fe4f9494166bed5b2f8 | 248 | Pfam | PF13638 | PIN domain | 33 | 159 | 8.1E-8 | T | 22-09-2020 | IPR002716 | PIN domain |
| UnnamedSample_HQ_transcript/53131|m.14667 | UnnamedSample_HQ_transcript/53131 | Coverage 0.912 too low. | 96b7f36825ae0c9e46c04a9114f0733d | 482 | Pfam | PF02752 | Arrestin (or S-antigen), C-terminal domain | 176 | 301 | 1.6E-18 | T | 22-09-2020 | IPR011022 | Arrestin C-terminal-like domain |
| UnnamedSample_HQ_transcript/53131|m.14667 | UnnamedSample_HQ_transcript/53131 | Coverage 0.912 too low. | 96b7f36825ae0c9e46c04a9114f0733d | 482 | Pfam | PF00339 | Arrestin (or S-antigen), N-terminal domain | 7 | 152 | 1.6E-37 | T | 22-09-2020 | IPR011021 | Arrestin-like, N-terminal |
| UnnamedSample_HQ_transcript/51062|m.14255 | UnnamedSample_HQ_transcript/51062 | Coverage 0.898 too low. | 96b7f36825ae0c9e46c04a9114f0733d | 482 | Pfam | PF02752 | Arrestin (or S-antigen), C-terminal domain | 176 | 301 | 1.6E-18 | T | 22-09-2020 | IPR011022 | Arrestin C-terminal-like domain |
| UnnamedSample_HQ_transcript/51062|m.14255 | UnnamedSample_HQ_transcript/51062 | Coverage 0.898 too low. | 96b7f36825ae0c9e46c04a9114f0733d | 482 | Pfam | PF00339 | Arrestin (or S-antigen), N-terminal domain | 7 | 152 | 1.6E-37 | T | 22-09-2020 | IPR011021 | Arrestin-like, N-terminal |
| UnnamedSample_HQ_transcript/52572|m.14562 | UnnamedSample_HQ_transcript/52572 | Coverage 0.900 too low. | 96b7f36825ae0c9e46c04a9114f0733d | 482 | Pfam | PF02752 | Arrestin (or S-antigen), C-terminal domain | 176 | 301 | 1.6E-18 | T | 22-09-2020 | IPR011022 | Arrestin C-terminal-like domain |
| UnnamedSample_HQ_transcript/52572|m.14562 | UnnamedSample_HQ_transcript/52572 | Coverage 0.900 too low. | 96b7f36825ae0c9e46c04a9114f0733d | 482 | Pfam | PF00339 | Arrestin (or S-antigen), N-terminal domain | 7 | 152 | 1.6E-37 | T | 22-09-2020 | IPR011021 | Arrestin-like, N-terminal |
| UnnamedSample_HQ_transcript/68097|m.17598 | UnnamedSample_HQ_transcript/68097 | Identity 0.880 too low. | ac8d9ec3ac3a96028e4bf0e146f0c1bb | 461 | Pfam | PF00089 | Trypsin | 34 | 242 | 2.1E-17 | T | 22-09-2020 | IPR001254 | Serine proteases, trypsin domain |
| UnnamedSample_HQ_transcript/115643|m.24457 | UnnamedSample_HQ_transcript/115643 | Coverage 0.892 too low. | a1b0185632ca7d754bf60a5b0156367e | 183 | Pfam | PF00012 | Hsp70 protein | 2 | 176 | 2.1E-33 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/39496|m.11743 | UnnamedSample_HQ_transcript/39496 | Coverage 0.938 too low. | 46787d8c24a99882f94defdbb096ac8c | 626 | Pfam | PF01457 | Leishmanolysin | 317 | 576 | 8.6E-37 | T | 22-09-2020 | IPR001577 | Peptidase M8, leishmanolysin |
| UnnamedSample_HQ_transcript/39496|m.11743 | UnnamedSample_HQ_transcript/39496 | Coverage 0.938 too low. | 46787d8c24a99882f94defdbb096ac8c | 626 | Pfam | PF01457 | Leishmanolysin | 140 | 253 | 1.8E-13 | T | 22-09-2020 | IPR001577 | Peptidase M8, leishmanolysin |
| UnnamedSample_HQ_transcript/29434|m.9338 | UnnamedSample_HQ_transcript/29434 | Coverage 0.167 too low. | 05407f6ebd9c8be88063a54f3d80b2c3 | 281 | Pfam | PF02214 | BTB/POZ domain | 39 | 127 | 2.6E-17 | T | 22-09-2020 | IPR003131 | Potassium channel tetramerisation-type BTB domain |
| UnnamedSample_HQ_transcript/36531|m.11053 | UnnamedSample_HQ_transcript/36531 | Identity 0.848 too low. | 0c7784798e6be24f2f978141cfd0df63 | 368 | Pfam | PF00501 | AMP-binding enzyme | 2 | 367 | 1.5E-59 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/1758|m.963 | UnnamedSample_HQ_transcript/1758 | Coverage 0.347 too low. | 9819eca3311b89fb50fe135f1da886a3 | 1377 | Pfam | PF16471 | JNK-interacting protein leucine zipper II | 374 | 444 | 2.7E-31 | T | 22-09-2020 | IPR032486 | JNK-interacting protein, leucine zipper II |
| UnnamedSample_HQ_transcript/1758|m.963 | UnnamedSample_HQ_transcript/1758 | Coverage 0.347 too low. | 9819eca3311b89fb50fe135f1da886a3 | 1377 | Pfam | PF09744 | JNK_SAPK-associated protein-1 | 21 | 175 | 1.8E-52 | T | 22-09-2020 | IPR019143 | JNK/Rab-associated protein-1, N-terminal |
| UnnamedSample_HQ_transcript/1758|m.963 | UnnamedSample_HQ_transcript/1758 | Coverage 0.347 too low. | 9819eca3311b89fb50fe135f1da886a3 | 1377 | Pfam | PF19056 | WD40 repeated domain | 999 | 1214 | 6.1E-49 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/5977|m.2535 | UnnamedSample_HQ_transcript/5977 | Coverage 0.962 too low. | dba04a05fc8a4b2b5793f6d0b303855e | 1147 | Pfam | PF00704 | Glycosyl hydrolases family 18 | 260 | 604 | 3.3E-95 | T | 22-09-2020 | IPR001223 | Glycoside hydrolase family 18, catalytic domain |
| UnnamedSample_HQ_transcript/5977|m.2535 | UnnamedSample_HQ_transcript/5977 | Coverage 0.962 too low. | dba04a05fc8a4b2b5793f6d0b303855e | 1147 | Pfam | PF01607 | Chitin binding Peritrophin-A domain | 1090 | 1137 | 8.5E-12 | T | 22-09-2020 | IPR002557 | Chitin binding domain |
| UnnamedSample_HQ_transcript/5977|m.2535 | UnnamedSample_HQ_transcript/5977 | Coverage 0.962 too low. | dba04a05fc8a4b2b5793f6d0b303855e | 1147 | Pfam | PF00704 | Glycosyl hydrolases family 18 | 692 | 1030 | 5.1E-96 | T | 22-09-2020 | IPR001223 | Glycoside hydrolase family 18, catalytic domain |
| UnnamedSample_HQ_transcript/34185|m.10517 | UnnamedSample_HQ_transcript/34185 | Coverage 0.560 too low. | fd96293de497d66d717da5f26ee9bec4 | 360 | Pfam | PF01244 | Membrane dipeptidase (Peptidase family M19) | 56 | 358 | 4.3E-75 | T | 22-09-2020 | IPR008257 | Peptidase M19 |
| UnnamedSample_HQ_transcript/90616|m.21346 | UnnamedSample_HQ_transcript/90616 | Coverage 0.086 too low. | fd96293de497d66d717da5f26ee9bec4 | 360 | Pfam | PF01244 | Membrane dipeptidase (Peptidase family M19) | 56 | 358 | 4.3E-75 | T | 22-09-2020 | IPR008257 | Peptidase M19 |
| UnnamedSample_HQ_transcript/124189|m.25088 | UnnamedSample_HQ_transcript/124189 | Coverage 0.975 too low. | 9c1a96638262ab1804af720cf0264531 | 105 | Pfam | PF00160 | Cyclophilin type peptidyl-prolyl cis-trans isomerase/CLD | 7 | 88 | 7.9E-26 | T | 22-09-2020 | IPR002130 | Cyclophilin-type peptidyl-prolyl cis-trans isomerase domain |
| UnnamedSample_HQ_transcript/11819|m.4432 | UnnamedSample_HQ_transcript/11819 | Identity 0.840 too low. | c2e1647a385b6129f4578ca1b4ee17f2 | 837 | Pfam | PF00385 | Chromo (CHRromatin Organisation MOdifier) domain | 69 | 132 | 1.9E-16 | T | 22-09-2020 | IPR023780 | Chromo domain |
| UnnamedSample_HQ_transcript/11819|m.4432 | UnnamedSample_HQ_transcript/11819 | Identity 0.840 too low. | c2e1647a385b6129f4578ca1b4ee17f2 | 837 | Pfam | PF00176 | SNF2 family N-terminal domain | 187 | 454 | 8.0E-63 | T | 22-09-2020 | IPR000330 | SNF2-related, N-terminal domain |
| UnnamedSample_HQ_transcript/11819|m.4432 | UnnamedSample_HQ_transcript/11819 | Identity 0.840 too low. | c2e1647a385b6129f4578ca1b4ee17f2 | 837 | Pfam | PF00271 | Helicase conserved C-terminal domain | 481 | 593 | 5.2E-20 | T | 22-09-2020 | IPR001650 | Helicase, C-terminal |
| UnnamedSample_HQ_transcript/116704|m.24555 | UnnamedSample_HQ_transcript/116704 | Coverage 0.984 too low. | 65f8bd35d45b27c1b7b375ca6d35c02a | 151 | Pfam | PF11568 | Mediator complex subunit 29 | 13 | 147 | 4.4E-49 | T | 22-09-2020 | IPR021018 | Mediator complex, subunit Med29, metazoa |
| UnnamedSample_HQ_transcript/109619|m.23787 | UnnamedSample_HQ_transcript/109619 | Coverage 0.974 too low. | 65f8bd35d45b27c1b7b375ca6d35c02a | 151 | Pfam | PF11568 | Mediator complex subunit 29 | 13 | 147 | 4.4E-49 | T | 22-09-2020 | IPR021018 | Mediator complex, subunit Med29, metazoa |
| UnnamedSample_HQ_transcript/66243|m.17256 | UnnamedSample_HQ_transcript/66243 | Identity 0.824 too low. | c223ffcb68e2a6af1eefe9439dad6cdd | 232 | Pfam | PF00017 | SH2 domain | 44 | 122 | 2.1E-10 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/28181|m.9011 | UnnamedSample_HQ_transcript/28181 | Coverage 0.987 too low. | 8dfd5399b3b4f97f649c46650280044b | 878 | Pfam | PF00005 | ABC transporter | 645 | 780 | 3.5E-20 | T | 22-09-2020 | IPR003439 | ABC transporter-like |
| UnnamedSample_HQ_transcript/28181|m.9011 | UnnamedSample_HQ_transcript/28181 | Coverage 0.987 too low. | 8dfd5399b3b4f97f649c46650280044b | 878 | Pfam | PF00664 | ABC transporter transmembrane region | 319 | 584 | 2.3E-32 | T | 22-09-2020 | IPR011527 | ABC transporter type 1, transmembrane domain |
| UnnamedSample_HQ_transcript/88786|m.21052 | UnnamedSample_HQ_transcript/88786 | Identity 0.904 too low. | 092eed5a7664fe2dacb71676ccb313f1 | 235 | Pfam | PF13869 | Nucleotide hydrolase | 45 | 230 | 9.2E-79 | T | 22-09-2020 | IPR016706 | Cleavage/polyadenylation specificity factor subunit 5 |
| UnnamedSample_HQ_transcript/86417|m.20709 | UnnamedSample_HQ_transcript/86417 | Identity 0.899 too low. | 092eed5a7664fe2dacb71676ccb313f1 | 235 | Pfam | PF13869 | Nucleotide hydrolase | 45 | 230 | 9.2E-79 | T | 22-09-2020 | IPR016706 | Cleavage/polyadenylation specificity factor subunit 5 |
| UnnamedSample_HQ_transcript/104350|m.23150 | UnnamedSample_HQ_transcript/104350 | Coverage 0.818 too low. | 092eed5a7664fe2dacb71676ccb313f1 | 235 | Pfam | PF13869 | Nucleotide hydrolase | 45 | 230 | 9.2E-79 | T | 22-09-2020 | IPR016706 | Cleavage/polyadenylation specificity factor subunit 5 |
| UnnamedSample_HQ_transcript/17635|m.6200 | UnnamedSample_HQ_transcript/17635 | Coverage 0.036 too low. | 0aaaa395ffaefadf02f6ed6d79cb3e67 | 498 | Pfam | PF10033 | Autophagy-related protein 13 | 92 | 191 | 1.5E-9 | T | 22-09-2020 | IPR018731 | Autophagy-related protein 13, N-terminal |
| UnnamedSample_HQ_transcript/44082|m.12733 | UnnamedSample_HQ_transcript/44082 | Identity 0.934 too low. | 9cabc739bc2086a241c2b2e2fa0b48fa | 427 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 36 | 424 | 1.5E-85 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/38890|m.11601 | UnnamedSample_HQ_transcript/38890 | Identity 0.932 too low. | 9cabc739bc2086a241c2b2e2fa0b48fa | 427 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 36 | 424 | 1.5E-85 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/997|m.626 | UnnamedSample_HQ_transcript/997 | Coverage 0.523 too low. | 976fe80281b4ca55b81cae5944d124cf | 1364 | Pfam | PF00630 | Filamin/ABP280 repeat | 151 | 243 | 4.8E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/997|m.626 | UnnamedSample_HQ_transcript/997 | Coverage 0.523 too low. | 976fe80281b4ca55b81cae5944d124cf | 1364 | Pfam | PF00630 | Filamin/ABP280 repeat | 633 | 723 | 1.3E-14 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/997|m.626 | UnnamedSample_HQ_transcript/997 | Coverage 0.523 too low. | 976fe80281b4ca55b81cae5944d124cf | 1364 | Pfam | PF00630 | Filamin/ABP280 repeat | 1152 | 1206 | 1.4E-8 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/997|m.626 | UnnamedSample_HQ_transcript/997 | Coverage 0.523 too low. | 976fe80281b4ca55b81cae5944d124cf | 1364 | Pfam | PF00630 | Filamin/ABP280 repeat | 51 | 143 | 7.5E-16 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/997|m.626 | UnnamedSample_HQ_transcript/997 | Coverage 0.523 too low. | 976fe80281b4ca55b81cae5944d124cf | 1364 | Pfam | PF00630 | Filamin/ABP280 repeat | 1024 | 1103 | 7.6E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/997|m.626 | UnnamedSample_HQ_transcript/997 | Coverage 0.523 too low. | 976fe80281b4ca55b81cae5944d124cf | 1364 | Pfam | PF00630 | Filamin/ABP280 repeat | 250 | 340 | 4.9E-14 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/997|m.626 | UnnamedSample_HQ_transcript/997 | Coverage 0.523 too low. | 976fe80281b4ca55b81cae5944d124cf | 1364 | Pfam | PF00630 | Filamin/ABP280 repeat | 824 | 914 | 3.3E-14 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/997|m.626 | UnnamedSample_HQ_transcript/997 | Coverage 0.523 too low. | 976fe80281b4ca55b81cae5944d124cf | 1364 | Pfam | PF00630 | Filamin/ABP280 repeat | 442 | 530 | 7.4E-15 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/997|m.626 | UnnamedSample_HQ_transcript/997 | Coverage 0.523 too low. | 976fe80281b4ca55b81cae5944d124cf | 1364 | Pfam | PF00630 | Filamin/ABP280 repeat | 1216 | 1298 | 1.2E-18 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/997|m.626 | UnnamedSample_HQ_transcript/997 | Coverage 0.523 too low. | 976fe80281b4ca55b81cae5944d124cf | 1364 | Pfam | PF00630 | Filamin/ABP280 repeat | 347 | 430 | 1.0E-15 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/997|m.626 | UnnamedSample_HQ_transcript/997 | Coverage 0.523 too low. | 976fe80281b4ca55b81cae5944d124cf | 1364 | Pfam | PF00630 | Filamin/ABP280 repeat | 731 | 817 | 5.6E-20 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/997|m.626 | UnnamedSample_HQ_transcript/997 | Coverage 0.523 too low. | 976fe80281b4ca55b81cae5944d124cf | 1364 | Pfam | PF00630 | Filamin/ABP280 repeat | 538 | 625 | 2.7E-14 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/997|m.626 | UnnamedSample_HQ_transcript/997 | Coverage 0.523 too low. | 976fe80281b4ca55b81cae5944d124cf | 1364 | Pfam | PF00630 | Filamin/ABP280 repeat | 921 | 1012 | 1.7E-13 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/3205|m.1526 | UnnamedSample_HQ_transcript/3205 | Coverage 0.937 too low. | 6f5e86e327144f08fb9034016b9d346c | 1605 | Pfam | PF02412 | Thrombospondin type 3 repeat | 1131 | 1166 | 1.2E-11 | T | 22-09-2020 | IPR003367 | Thrombospondin, type 3-like repeat |
| UnnamedSample_HQ_transcript/3205|m.1526 | UnnamedSample_HQ_transcript/3205 | Coverage 0.937 too low. | 6f5e86e327144f08fb9034016b9d346c | 1605 | Pfam | PF02412 | Thrombospondin type 3 repeat | 1291 | 1325 | 1.3E-9 | T | 22-09-2020 | IPR003367 | Thrombospondin, type 3-like repeat |
| UnnamedSample_HQ_transcript/3205|m.1526 | UnnamedSample_HQ_transcript/3205 | Coverage 0.937 too low. | 6f5e86e327144f08fb9034016b9d346c | 1605 | Pfam | PF02412 | Thrombospondin type 3 repeat | 1252 | 1289 | 7.9E-10 | T | 22-09-2020 | IPR003367 | Thrombospondin, type 3-like repeat |
| UnnamedSample_HQ_transcript/3205|m.1526 | UnnamedSample_HQ_transcript/3205 | Coverage 0.937 too low. | 6f5e86e327144f08fb9034016b9d346c | 1605 | Pfam | PF02412 | Thrombospondin type 3 repeat | 1193 | 1228 | 1.5E-12 | T | 22-09-2020 | IPR003367 | Thrombospondin, type 3-like repeat |
| UnnamedSample_HQ_transcript/3205|m.1526 | UnnamedSample_HQ_transcript/3205 | Coverage 0.937 too low. | 6f5e86e327144f08fb9034016b9d346c | 1605 | Pfam | PF02412 | Thrombospondin type 3 repeat | 1326 | 1359 | 5.9E-12 | T | 22-09-2020 | IPR003367 | Thrombospondin, type 3-like repeat |
| UnnamedSample_HQ_transcript/3205|m.1526 | UnnamedSample_HQ_transcript/3205 | Coverage 0.937 too low. | 6f5e86e327144f08fb9034016b9d346c | 1605 | Pfam | PF11598 | Cartilage oligomeric matrix protein | 216 | 256 | 2.6E-7 | T | 22-09-2020 | IPR024665 | Thrombospondin/cartilage oligomeric matrix protein, coiled-coil domain |
| UnnamedSample_HQ_transcript/3205|m.1526 | UnnamedSample_HQ_transcript/3205 | Coverage 0.937 too low. | 6f5e86e327144f08fb9034016b9d346c | 1605 | Pfam | PF05735 | Thrombospondin C-terminal region | 1379 | 1576 | 3.0E-93 | T | 22-09-2020 | IPR008859 | Thrombospondin, C-terminal |
| UnnamedSample_HQ_transcript/59723|m.16003 | UnnamedSample_HQ_transcript/59723 | Coverage 0.803 too low. | 26b8199b5031a6f0f4217ae96da6724d | 460 | Pfam | PF00012 | Hsp70 protein | 1 | 311 | 1.1E-82 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/69032|m.17767 | UnnamedSample_HQ_transcript/69032 | Coverage 0.891 too low. | 542bb81b53b43b7a1613ea18cc02dfa2 | 345 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 16 | 84 | 2.9E-14 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/69032|m.17767 | UnnamedSample_HQ_transcript/69032 | Coverage 0.891 too low. | 542bb81b53b43b7a1613ea18cc02dfa2 | 345 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 107 | 164 | 1.5E-16 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/26758|m.8666 | UnnamedSample_HQ_transcript/26758 | Coverage 0.715 too low. | 7c97d887cdfacba863f8191e08e1abf7 | 549 | Pfam | PF00135 | Carboxylesterase family | 18 | 533 | 9.8E-138 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/105774|m.23313 | UnnamedSample_HQ_transcript/105774 | Coverage 0.988 too low. | fbf24f895004926d3768db04ce9e5cf0 | 252 | Pfam | PF03265 | Deoxyribonuclease II | 11 | 252 | 2.1E-62 | T | 22-09-2020 | IPR004947 | Deoxyribonuclease II |
| UnnamedSample_HQ_transcript/1360|m.788 | UnnamedSample_HQ_transcript/1360 | Coverage 0.965 too low. | fdd78a2a00a2d8da56974f6f03e6cdfd | 1831 | Pfam | PF17960 | TIG domain | 397 | 484 | 1.1E-9 | T | 22-09-2020 | IPR041019 | Plexin, TIG domain 1 |
| UnnamedSample_HQ_transcript/1360|m.788 | UnnamedSample_HQ_transcript/1360 | Coverage 0.965 too low. | fdd78a2a00a2d8da56974f6f03e6cdfd | 1831 | Pfam | PF01833 | IPT/TIG domain | 764 | 854 | 6.4E-6 | T | 22-09-2020 | IPR002909 | IPT domain |
| UnnamedSample_HQ_transcript/1360|m.788 | UnnamedSample_HQ_transcript/1360 | Coverage 0.965 too low. | fdd78a2a00a2d8da56974f6f03e6cdfd | 1831 | Pfam | PF01833 | IPT/TIG domain | 1067 | 1124 | 2.7E-5 | T | 22-09-2020 | IPR002909 | IPT domain |
| UnnamedSample_HQ_transcript/1360|m.788 | UnnamedSample_HQ_transcript/1360 | Coverage 0.965 too low. | fdd78a2a00a2d8da56974f6f03e6cdfd | 1831 | Pfam | PF01833 | IPT/TIG domain | 859 | 937 | 5.3E-11 | T | 22-09-2020 | IPR002909 | IPT domain |
| UnnamedSample_HQ_transcript/1360|m.788 | UnnamedSample_HQ_transcript/1360 | Coverage 0.965 too low. | fdd78a2a00a2d8da56974f6f03e6cdfd | 1831 | Pfam | PF01403 | Sema domain | 53 | 306 | 6.2E-19 | T | 22-09-2020 | IPR001627 | Sema domain |
| UnnamedSample_HQ_transcript/1360|m.788 | UnnamedSample_HQ_transcript/1360 | Coverage 0.965 too low. | fdd78a2a00a2d8da56974f6f03e6cdfd | 1831 | Pfam | PF08337 | Plexin cytoplasmic RasGAP domain | 1243 | 1798 | 2.1E-203 | T | 22-09-2020 | IPR013548 | Plexin, cytoplasmic RasGAP domain |
| UnnamedSample_HQ_transcript/74248|m.18691 | UnnamedSample_HQ_transcript/74248 | Unmapped. | 592219305854ef155eaa59022b89b226 | 343 | Pfam | PF05667 | Protein of unknown function (DUF812) | 1 | 243 | 3.4E-47 | T | 22-09-2020 | IPR008530 | Coiled-coil domain-containing protein 22 |
| UnnamedSample_HQ_transcript/89425|m.21152 | UnnamedSample_HQ_transcript/89425 | Coverage 0.817 too low. | 57249595993cb467fdfb91e2d68d03af | 418 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 122 | 179 | 2.7E-9 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/89425|m.21152 | UnnamedSample_HQ_transcript/89425 | Coverage 0.817 too low. | 57249595993cb467fdfb91e2d68d03af | 418 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 48 | 111 | 8.1E-12 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/89425|m.21152 | UnnamedSample_HQ_transcript/89425 | Coverage 0.817 too low. | 57249595993cb467fdfb91e2d68d03af | 418 | Pfam | PF08075 | NOPS (NUC059) domain | 192 | 244 | 5.9E-24 | T | 22-09-2020 | IPR012975 | NOPS |
| UnnamedSample_HQ_transcript/6583|m.2734 | UnnamedSample_HQ_transcript/6583 | Coverage 0.950 too low. | 4d7cda349104f927d6e8201d34b3ad71 | 1229 | Pfam | PF00027 | Cyclic nucleotide-binding domain | 158 | 251 | 4.2E-11 | T | 22-09-2020 | IPR000595 | Cyclic nucleotide-binding domain |
| UnnamedSample_HQ_transcript/6583|m.2734 | UnnamedSample_HQ_transcript/6583 | Coverage 0.950 too low. | 4d7cda349104f927d6e8201d34b3ad71 | 1229 | Pfam | PF00027 | Cyclic nucleotide-binding domain | 462 | 551 | 9.2E-10 | T | 22-09-2020 | IPR000595 | Cyclic nucleotide-binding domain |
| UnnamedSample_HQ_transcript/6583|m.2734 | UnnamedSample_HQ_transcript/6583 | Coverage 0.950 too low. | 4d7cda349104f927d6e8201d34b3ad71 | 1229 | Pfam | PF00027 | Cyclic nucleotide-binding domain | 583 | 662 | 3.9E-15 | T | 22-09-2020 | IPR000595 | Cyclic nucleotide-binding domain |
| UnnamedSample_HQ_transcript/6583|m.2734 | UnnamedSample_HQ_transcript/6583 | Coverage 0.950 too low. | 4d7cda349104f927d6e8201d34b3ad71 | 1229 | Pfam | PF01734 | Patatin-like phospholipase | 904 | 1068 | 2.9E-20 | T | 22-09-2020 | IPR002641 | Patatin-like phospholipase domain |
| UnnamedSample_HQ_transcript/49151|m.13842 | UnnamedSample_HQ_transcript/49151 | Coverage 0.136 too low. | a1a1785ddd5a50f4ed2af0d76fe6546e | 631 | Pfam | PF00178 | Ets-domain | 524 | 603 | 1.8E-33 | T | 22-09-2020 | IPR000418 | Ets domain |
| UnnamedSample_HQ_transcript/49151|m.13842 | UnnamedSample_HQ_transcript/49151 | Coverage 0.136 too low. | a1a1785ddd5a50f4ed2af0d76fe6546e | 631 | Pfam | PF02198 | Sterile alpha motif (SAM)/Pointed domain | 109 | 190 | 8.8E-32 | T | 22-09-2020 | IPR003118 | Pointed domain |
| UnnamedSample_HQ_transcript/50103|m.14044 | UnnamedSample_HQ_transcript/50103 | Coverage 0.139 too low. | a1a1785ddd5a50f4ed2af0d76fe6546e | 631 | Pfam | PF00178 | Ets-domain | 524 | 603 | 1.8E-33 | T | 22-09-2020 | IPR000418 | Ets domain |
| UnnamedSample_HQ_transcript/50103|m.14044 | UnnamedSample_HQ_transcript/50103 | Coverage 0.139 too low. | a1a1785ddd5a50f4ed2af0d76fe6546e | 631 | Pfam | PF02198 | Sterile alpha motif (SAM)/Pointed domain | 109 | 190 | 8.8E-32 | T | 22-09-2020 | IPR003118 | Pointed domain |
| UnnamedSample_HQ_transcript/56948|m.15433 | UnnamedSample_HQ_transcript/56948 | Coverage 0.094 too low. | a1a1785ddd5a50f4ed2af0d76fe6546e | 631 | Pfam | PF00178 | Ets-domain | 524 | 603 | 1.8E-33 | T | 22-09-2020 | IPR000418 | Ets domain |
| UnnamedSample_HQ_transcript/56948|m.15433 | UnnamedSample_HQ_transcript/56948 | Coverage 0.094 too low. | a1a1785ddd5a50f4ed2af0d76fe6546e | 631 | Pfam | PF02198 | Sterile alpha motif (SAM)/Pointed domain | 109 | 190 | 8.8E-32 | T | 22-09-2020 | IPR003118 | Pointed domain |
| UnnamedSample_HQ_transcript/76362|m.19089 | UnnamedSample_HQ_transcript/76362 | Coverage 0.473 too low. | 2f7a35498b595e17d1c9896518fe7669 | 410 | Pfam | PF00083 | Sugar (and other) transporter | 6 | 375 | 3.1E-45 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/81959|m.20024 | UnnamedSample_HQ_transcript/81959 | Coverage 0.510 too low. | 2f7a35498b595e17d1c9896518fe7669 | 410 | Pfam | PF00083 | Sugar (and other) transporter | 6 | 375 | 3.1E-45 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/106899|m.23444 | UnnamedSample_HQ_transcript/106899 | Coverage 0.984 too low. | a1b40a49b0a9377062c53168d7b6d1dc | 247 | Pfam | PF05833 | Fibronectin-binding protein A N-terminus (FbpA) | 9 | 226 | 5.5E-33 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/102262|m.22900 | UnnamedSample_HQ_transcript/102262 | Unmapped. | dc33c9c9135c5d9c05b6c8fbc41dc3cf | 324 | Pfam | PF08762 | CRPV capsid protein like | 26 | 236 | 3.5E-13 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/51260|m.14294 | UnnamedSample_HQ_transcript/51260 | Identity 0.811 too low. | d50d26c578af60006b9fe47086375610 | 202 | Pfam | PF00069 | Protein kinase domain | 6 | 128 | 7.2E-22 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/46238|m.13193 | UnnamedSample_HQ_transcript/46238 | Coverage 0.964 too low. | d50d26c578af60006b9fe47086375610 | 202 | Pfam | PF00069 | Protein kinase domain | 6 | 128 | 7.2E-22 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/87396|m.20857 | UnnamedSample_HQ_transcript/87396 | Identity 0.928 too low. | fce0ee6e34f81023488358badad25f8a | 296 | Pfam | PF18345 | Zinc finger domain | 105 | 123 | 3.8E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/87396|m.20857 | UnnamedSample_HQ_transcript/87396 | Identity 0.928 too low. | fce0ee6e34f81023488358badad25f8a | 296 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 174 | 228 | 1.2E-9 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/99748|m.22597 | UnnamedSample_HQ_transcript/99748 | Identity 0.786 too low. | d952594bf60cb73d55c33176b1b8c2f7 | 200 | Pfam | PF07479 | NAD-dependent glycerol-3-phosphate dehydrogenase C-terminus | 46 | 191 | 3.6E-49 | T | 22-09-2020 | IPR006109 | Glycerol-3-phosphate dehydrogenase, NAD-dependent, C-terminal |
| UnnamedSample_HQ_transcript/10379|m.3952 | UnnamedSample_HQ_transcript/10379 | Coverage 0.955 too low. | 9495c031b9194618e240c7ecfbb069a1 | 380 | Pfam | PF02826 | D-isomer specific 2-hydroxyacid dehydrogenase, NAD binding domain | 134 | 318 | 2.0E-55 | T | 22-09-2020 | IPR006140 | D-isomer specific 2-hydroxyacid dehydrogenase, NAD-binding domain |
| UnnamedSample_HQ_transcript/10379|m.3952 | UnnamedSample_HQ_transcript/10379 | Coverage 0.955 too low. | 9495c031b9194618e240c7ecfbb069a1 | 380 | Pfam | PF00389 | D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain | 39 | 353 | 2.9E-29 | T | 22-09-2020 | IPR006139 | D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain |
| UnnamedSample_HQ_transcript/25734|m.8405 | UnnamedSample_HQ_transcript/25734 | Coverage 0.645 too low. | 673bf90a595e2bc2e1a99dfdded62115 | 596 | Pfam | PF00413 | Matrixin | 141 | 294 | 1.1E-57 | T | 22-09-2020 | IPR001818 | Peptidase M10, metallopeptidase |
| UnnamedSample_HQ_transcript/25734|m.8405 | UnnamedSample_HQ_transcript/25734 | Coverage 0.645 too low. | 673bf90a595e2bc2e1a99dfdded62115 | 596 | Pfam | PF01471 | Putative peptidoglycan binding domain | 62 | 114 | 5.5E-7 | T | 22-09-2020 | IPR002477 | Peptidoglycan binding-like |
| UnnamedSample_HQ_transcript/25734|m.8405 | UnnamedSample_HQ_transcript/25734 | Coverage 0.645 too low. | 673bf90a595e2bc2e1a99dfdded62115 | 596 | Pfam | PF00045 | Hemopexin | 444 | 485 | 1.8E-11 | T | 22-09-2020 | IPR018487 | Hemopexin-like repeats |
| UnnamedSample_HQ_transcript/25734|m.8405 | UnnamedSample_HQ_transcript/25734 | Coverage 0.645 too low. | 673bf90a595e2bc2e1a99dfdded62115 | 596 | Pfam | PF00045 | Hemopexin | 489 | 535 | 4.8E-10 | T | 22-09-2020 | IPR018487 | Hemopexin-like repeats |
| UnnamedSample_HQ_transcript/25734|m.8405 | UnnamedSample_HQ_transcript/25734 | Coverage 0.645 too low. | 673bf90a595e2bc2e1a99dfdded62115 | 596 | Pfam | PF00045 | Hemopexin | 347 | 390 | 1.1E-7 | T | 22-09-2020 | IPR018487 | Hemopexin-like repeats |
| UnnamedSample_HQ_transcript/25734|m.8405 | UnnamedSample_HQ_transcript/25734 | Coverage 0.645 too low. | 673bf90a595e2bc2e1a99dfdded62115 | 596 | Pfam | PF00045 | Hemopexin | 393 | 436 | 3.7E-16 | T | 22-09-2020 | IPR018487 | Hemopexin-like repeats |
| UnnamedSample_HQ_transcript/19209|m.6638 | UnnamedSample_HQ_transcript/19209 | Coverage 0.676 too low. | 673bf90a595e2bc2e1a99dfdded62115 | 596 | Pfam | PF00413 | Matrixin | 141 | 294 | 1.1E-57 | T | 22-09-2020 | IPR001818 | Peptidase M10, metallopeptidase |
| UnnamedSample_HQ_transcript/19209|m.6638 | UnnamedSample_HQ_transcript/19209 | Coverage 0.676 too low. | 673bf90a595e2bc2e1a99dfdded62115 | 596 | Pfam | PF01471 | Putative peptidoglycan binding domain | 62 | 114 | 5.5E-7 | T | 22-09-2020 | IPR002477 | Peptidoglycan binding-like |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
